E. A. Dondurey

E. A. Dondurey

Auto-generated profile, based on publicly available information

E. A. Dondurey

Smorodintsev Research Institute of Influenza 620030 Новосибирск г. Екатеринбург Россия Россия

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
OAO. I. Afanasyeva
O. I. Afanasyeva
EGE. G. Golovacheva
E. G. Golovacheva
LOL. V. Osidak
L. V. Osidak
VTV. S. Timonina
V. S. Timonina
VGV. V. Gonchar
V. V. Gonchar
DLDmitry Lioznov
Dmitry Lioznov
Objective: to study the dynamics of local and systemic cytokine production in children with different clinical forms of acute respiratory viral infections (ARVI), including COVID-19, and to assess the effectiveness of local interferon-based therapy.Patients and methods: The study included 180 patients aged from 1 month to 17 years with сonfirmed acute respiratory viral infections (ARVI), including COVID-19. Patients were divided into 2 groups (main and control) of 90 people each. In the main group patients received the intranasal interferon-based medicine Grippferon® in addition to the basic therapy, the control group patients received only basic therapy. The cytokine status was assessed by the content of IFN-α and -γ, IL-1β, IL-8, IL-4, IL-10, IL-17 in blood serum and in nasopharyngeal secretions by enzyme immunoassay kits ("Cytokine", St. Petersburg).Results: Statistically significant differences were revealed in the systemic and local content of individual cytokines in ARVI of different etiologies, depending on the level of damage to the respiratory tract. The use of the interferon-based medicine Grippferon® for intranasal use in children in the early stages of ARVI, including COVID-19, helps to decrease the high content of cytokines IL-1β and IL-8 in the nasopharynx by reducing the viral load. As a result, the duration of catarrhal disease symptoms and intoxication was also significantly reduced as well as the pathogen elimination time.

21 July 2025 in Problems of Virology
Verified
Journal Article
Open access
PDF file
ASAnna Sominina
Anna Sominina
DDDaria Danilenko
Daria Danilenko
AKAndrey Komissarov
Andrey Komissarov
AFArtem Fadeev
Artem Fadeev
KKKseniia Komissarova
Kseniia Komissarova
DLDmitry Lioznov
Dmitry Lioznov
Objective. To analyze the age-related characteristics of the contribution of influenza viruses, RSV, SARS-CoV-2, other pathogens to the development of severe acute respiratory infections (SARI) in children with an assessment of the disease severity depending on its etiology and epidemic period. Materials and methods. SARI monitoring was carried out over six consecutive epidemic seasons, starting from 2018–2019 in 9 infectious hospitals of three cities of Russia with an assessment of the disease severity depending on its etiology. Results. Among all hospitalized children, the proportion of children hospitalized with laboratory-confirmed influenza from 2018 to 2020 ranged from 25.7% to 44.7%, and for RSV infection from 25.7% to 26.8%. However, during the peak of the pandemic, these rates dropped significantly to 0.3% and 1.7%, respectively. In the subsequent three seasons (2021–2024), laboratory-confirmed influenza among hospitalized children was registered in 4.5–20.2% of cases, while RSV infection was identified in 13.4–24.1% of cases, accompanied by a shift in viral subgroups. RSV infections were most severe during the 2022–2023 season, presenting in some cases with hyperthermia, hypoxia, dyspnea, and altered consciousness. Among hospitalized children, the proportion with COVID-19 was relatively low in 2020–2021 (0.8–2.4%) but increased significantly to 10.6%–13.6% following the emergence of the Omicron variant in 2022, before decreasing again in subsequent years. The main genetic lineages of SARS-CoV-2 circulating in the Russian Federation are presented. Conclusion. Influenza and RSV viruses were predominant among viral pathogens identified in hospitalized children aged ≤ 2 years. COVID-19 cases among children were relatively rare and generally less severe compared to RSV and rhinovirus infections.

1 January 2025 in Infectious diseases: News, Opinions, Training
Verified
Journal Article
Open access
AMA.B. Malakhov
A.B. Malakhov
NGNatalia Geppe
Natalia Geppe
AGA.V. Gorelov
A.V. Gorelov
МKМikhail Petrovich Kostinov
Мikhail Petrovich Kostinov
TCT.A. Chebotareva
T.A. Chebotareva
ASA.V. Shishova
A.V. Shishova
Согласованное мнение экспертов по вопросам иммунопрофилактики респираторных инфекций XIV Международного образовательного консенсуса по респираторной

1 April 2023 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
EDE. А. Dondurey
E. А. Dondurey
ИКИрина Максимовна Косенко
Ирина Максимовна Косенко
EKE. Kostitsyna
E. Kostitsyna
YPY. Polkovnikova
Y. Polkovnikova
ASA. Shestakova
A. Shestakova
Влияние пробиотиков на продолжительность осмо-секреторной диареи при острых кишечных инфекциях у детей